When was Cardiovascular Systems founded?

Cardiovascular Systems was founded in 1989 and raised its 1st funding round 13 years after it was founded.

Where is Cardiovascular Systems located?

Cardiovascular Systems is headquartered in Saint Paul, United States. It is registered at 1225 Old Highway 8 NW St. Paul, MN 55112.

How many employees does Cardiovascular Systems have?

As of Jul 31, 2026, the latest employee count at Cardiovascular Systems is 264.

Is Cardiovascular Systems a funded company?

Cardiovascular Systems is a funded company, having raised a total of $121M across 10 funding rounds to date. The company's 1st funding round was a $***** Unattributed round, raised on Aug 14, 2002.

How much is Cardiovascular Systems worth?

The last known valuation of Cardiovascular Systems was $***** as of Feb 08, 2023.

When was the latest funding round of Cardiovascular Systems?

Cardiovascular Systems' latest funding was a $***** Post IPO round on Mar 12, 2013, with participation from 0 investor. Its primary sector is Cardiac and Vascular Disorders. In United States, the Cardiac and Vascular Disorders sector has seen $1.1B in funding in 2026 to date.

What is the annual revenue of Cardiovascular Systems?

Annual revenue of Cardiovascular Systems is between $100M and $500M as on Jun 30, 2022

Where does Cardiovascular Systems rank among its competitors?

Cardiovascular Systems ranks 9th amongst 128 active competitors, of which 36 are funded. It stands 1st in terms of total funding among its competitors. The most recent competitor to raise funding was Thrombolex, which secured $50M in Feb, 2026.

Who are the top competitors of Cardiovascular Systems?

Cardiovascular Systems' top competitors include SMT, Echopoint Medical and Thrombolex. Among them, Thrombolex secured the most recent funding round in February, 2026.

Cardiovascular Systems - 2026 Company Profile, Funding, Competitors & Financials

Cardiovascular Systems is an acquired company based in Saint Paul (United States), founded in 1989. It operates as a Developer of devices for treating peripheral and coronary vascular disease. Cardiovascular Systems has raised $121M in funding, with last known valuation of $*****. The company has 128 active competitors, including 36 funded and 33 that have exited. Its top competitors include companies like SMT, Echopoint Medical and Thrombolex.

Company Details

Developer of devices for treating peripheral and coronary vascular disease. The products include Orbital Atherectomy Systems treat calcified and fibrotic plaque in arterial vessels throughout the leg and heart.

Website: csi360.com
Registered Address: 1225 Old Highway 8 NW St. Paul, MN 55112

Key Metrics

Founded Year

1989

Location

Saint Paul, United States

Stage

Acquired

Total Funding

$121M in 10 rounds

Latest Funding Round

Post IPO, Mar 12, 2013, $*****

Last Known Valuation

$***** as on Feb 08, 2023

Investors

Maverick Ventures & 7 more

Ranked

9^th among 128 active competitors

Annual Revenue

$100M - $500M as on Jun 30, 2022

Employee Count

264 as on Jul 31, 2026

Investment & Acquisitions

CarePICS

Similar Companies

SMT & 163 more

Exit Details

Acquired by Abbott (Feb 08, 2023)

View Cardiovascular Systems' full profile

Cardiovascular Systems is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Cardiovascular Systems, Inc. CIN: 411698056 , United States, Active	Dec 05, 2000	-	741 (As on Dec 31, 2022)	-
CARDIOVASCULAR SYSTEMS INC CIN: 1180145 , United States, Active	Dec 05, 2000	$100M - $500M (As on Jun 30, 2022)	-	-

Cardiovascular Systems got acquired by Abbott on Feb 08, 2023.

Click here to take a look at Cardiovascular Systems's acquisition in detail

Cardiovascular Systems has raised a total funding of $121M over 10 rounds. Its first funding round was on Aug 14, 2002. Cardiovascular Systems has 8 institutional investors.

Here is the list of recent funding rounds of Cardiovascular Systems:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Mar 12, 2013	9402633	Post IPO	5813708	8208810	1395834	9129803
May 23, 2011	5935719	Post IPO	3085704	1618651	4341114	9770616
Dec 13, 2010	2065021	Post IPO	7637629	7302453	7409908	9716203

Access funding benchmarks and valuations. Sign up today!

View details of Cardiovascular Systems's funding rounds and investors

Cardiovascular Systems' employee count trend

Cardiovascular Systems has 264 employees as of Jul 26. Here is Cardiovascular Systems's employee count trend over the years:

Employee count trend for Cardiovascular Systems

Uncover Cardiovascular Systems' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Cardiovascular Systems include SMT, Echopoint Medical and Thrombolex. Here is the list of Top 10 competitors of Cardiovascular Systems, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	SMT 1998, Surat (India), Late Stage	Manufacturer of minimally invasive cardiovascular devices including coronary and structural heart	$93.5M	Samara Capital, Kotak Mahindra Bank & 105 others	71/100
2nd	Echopoint Medical 2018, London (United Kingdom), Series A	Developer of smart devices for monitoring coronary artery disease and microvascular dysfunction	$9.99M	UCL Technology Fund, Parkwalk & 3 others	59/100
3rd	Thrombolex 2016, Doylestown (United States), Series A	Developer of endovascular catheters for acute venous thromboembolic conditions	$67.8M	Orbimed, HHS	54/100
4th	Medyria 2012, Winterthur (Switzerland), Series B	Developer of technology for endovascular catheter navigation and sensing	$12.3M	Verve Ventures, Yellowstone Holding & 9 others	53/100
5th	Terumo Medical 1921, Shibuya (Japan), Funding Raised	Provider of a portfolio of medical devices for interventional cardiology	-	USAGov, BCM Technologies	53/100
6th	Vascular Solutions 1997, Minneapolis (United States), Acquired	Products for vascular diagnostics and interventional procedures	$12M	SpringRock Ventures, Stephens & 3 others	52/100
7th	iHeart 2013, Kyoto (Japan), Series D	Experts in regenerative medicine	$5.44M	SBI Investment, Japan Asia Investment & 5 others	51/100
8th	Sonovascular 2017, Chapel Hill (United States), Series A	eveloper of a medical device to treat arterial and venous diseases	$6M	NC State University, Harbright Ventures & 1 others	51/100
9th	Cardiovascular Systems 1989, Saint Paul (United States), Acquired	Developer of devices for treating peripheral and coronary vascular disease	$121M	Maverick Ventures, Mitsui Global Investment ... & 6 others	50/100
10th	Contego Medical 2005, Raleigh (United States), Series D	Provider of vascular stenting with embolic protection for both coronary and peripheral vasculature	$66M	Hatteras Venture Partners, Tidewater Investment Company ... & 7 others	49/100